Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/19428
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bassukas, I. D. | en |
dc.contributor.author | Kosmidou, M. | en |
dc.contributor.author | Gaitanis, G. | en |
dc.contributor.author | Tsiouri, G. | en |
dc.contributor.author | Tsianos, E. | en |
dc.date.accessioned | 2015-11-24T18:59:51Z | - |
dc.date.available | 2015-11-24T18:59:51Z | - |
dc.identifier.issn | 1651-2057 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/19428 | - |
dc.rights | Default Licence | - |
dc.subject | Adolescent | en |
dc.subject | Adult | en |
dc.subject | Aged | en |
dc.subject | Analysis of Variance | en |
dc.subject | Antitubercular Agents/*administration & dosage | en |
dc.subject | Biological Agents/*administration & dosage | en |
dc.subject | Colitis, Ulcerative/diagnosis/immunology/*therapy | en |
dc.subject | Crohn Disease/diagnosis/immunology/*therapy | en |
dc.subject | Drug Administration Schedule | en |
dc.subject | False Positive Reactions | en |
dc.subject | Female | en |
dc.subject | Greece | en |
dc.subject | Humans | en |
dc.subject | Latent Tuberculosis/diagnosis/*drug therapy/immunology | en |
dc.subject | Male | en |
dc.subject | Middle Aged | en |
dc.subject | Practice Guidelines as Topic | en |
dc.subject | Predictive Value of Tests | en |
dc.subject | Psoriasis/diagnosis/immunology/*therapy | en |
dc.subject | Retrospective Studies | en |
dc.subject | Severity of Illness Index | en |
dc.subject | Time Factors | en |
dc.subject | Tuberculin Test | en |
dc.subject | Tumor Necrosis Factor-alpha/*antagonists & inhibitors | en |
dc.subject | Young Adult | en |
dc.title | Patients with psoriasis are more likely to be treated for latent tuberculosis infection prior to biologics than patients with inflammatory bowel disease | en |
heal.type | journalArticle | - |
heal.type.en | Journal article | en |
heal.type.el | Άρθρο Περιοδικού | el |
heal.identifier.primary | 10.2340/00015555-1106 | - |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/21547342 | - |
heal.language | en | - |
heal.access | campus | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.publicationDate | 2011 | - |
heal.abstract | Screening for latent tuberculosis infection (LTBI) is recommended before treatment with biologics is initiated in patients with psoriasis or inflammatory bowel disease (IBD). Our objective was to evaluate the effect of underlying disease (psoriasis or IBD) on the risk of LTBI diagnosis prior to anti-tumor necrosis factor-alpha (TNF-alpha) therapy. During a two-year period LTBI diagnosis rate was compared in consecutive patients with psoriasis or IBD (Crohn's disease or ulcerative colitis). IBD patients (n = 33) had significantly smaller tuberculin skin testing compared to psoriasis patients (n = 30) (p = 0.007). Applying LTBI diagnosis guidelines resulted in more psoriasis (50%) than IBD patients (24.2%) receiving treatment for LTBI prior to onset of anti-TNF-alpha treatment (p = 0.04). In conclusion, current recommendations for LTBI diagnosis must be re-evaluated to account for the unique tuberculin hyperactive state of the skin of patients with psoriasis. | en |
heal.journalName | Acta Derm Venereol | en |
heal.journalType | peer-reviewed | - |
heal.fullTextAvailability | TRUE | - |
Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Gaitanis-2011-patients with psoriasis.pdf | 463.84 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License